NCT03256292

Brief Summary

Older hypogonadal obese veterans previously participated in a 6 month lifestyle change (diet-induced weight loss and exercise) study with or without testosterone replacement therapy before being followed for the following year at the clinic while receiving standard of care consisting of diet and exercise counseling (for healthy lifestyle change) and testosterone replacement therapy. This study will determine if long-term lifestyle change and testosterone replacement therapy with associated improvement in physical and metabolic health can be maintained in obese older adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2017

Completed
5 days until next milestone

Study Start

First participant enrolled

August 21, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 22, 2017

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2020

Completed
Last Updated

March 10, 2021

Status Verified

March 1, 2021

Enrollment Period

3 years

First QC Date

August 16, 2017

Last Update Submit

March 8, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Physical Performance Test score

    The primary functional outcome is the modified physical performance test, which includes seven standardized tasks (walking 50 ft, putting on and removing a coat, picking up a penny, standing up from a chair, lifting a book, climbing one flight of stairs, and performing a progressive Romberg tests) plus two additional tasks (climbing up and down four flights of stairs and performing a 360-degree turn). The score for each task ranges form 0 to 4; a perfect score is 36.

    18 month

  • Change in body weight

    Measured after an overnight fast using calibrated scales

    18 month

Secondary Outcomes (36)

  • Change in body composition (lean mass, fat mass and bone mineral density)

    18 month

  • Volumetric BMD

    18 month

  • Biochemical Markers of Bone Turnover (Serum C-terminal telopeptide (CTX)

    18 month

  • Change in prostate specific antigen

    18 month

  • Prostate Symptom Assessment

    18 month

  • +31 more secondary outcomes

Study Arms (1)

testosterone, diet, and increased physical activity

Group receiving standard of care consisting of diet and regular exercise counseling + testosterone replacement therapy

Drug: Testosterone replacementBehavioral: lifestyle

Interventions

Testosterone replacement therapy

testosterone, diet, and increased physical activity
lifestyleBEHAVIORAL

lifestyle intervention consisting of diet and increased physical activity

testosterone, diet, and increased physical activity

Eligibility Criteria

Age65 Years - 85 Years
Sexmale
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Older adults with hypogonadism following lifestyle change (diet and exercise on their own for at least one year) with testosterone replacement therapy.

You may qualify if:

  • Overweight/obese (BMI = or \> 27 kg/m2)
  • Older (65-85 yr)
  • Male veteran patients being seen at the PI's endocrine clinic and receiving standard of care consisting of diet and regular exercise counseling
  • Diagnosed with hypogonadism on current or previous testosterone replacement at the PI's endocrine clinic
  • Willing to provide informed consent

You may not qualify if:

  • Failure to provide informed consent
  • Unstable cardiopulmonary disease (e.g. recent MI, unstable angina, stroke) or unstable disease (Class III or IV congestive heart failure).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Michael E DeBakey VA Medical Center

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

HypogonadismOverweightObesity

Condition Hierarchy (Ancestors)

Gonadal DisordersEndocrine System DiseasesOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Dennis T Villareal, MD

    Baylor College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 16, 2017

First Posted

August 22, 2017

Study Start

August 21, 2017

Primary Completion

August 31, 2020

Study Completion

August 31, 2020

Last Updated

March 10, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will share

A De-identified, Anonymized Dataset will be created and shared. NOTE: ORO recommends that such sharing take place under a written agreement that adheres to any applicable Informed Consent provisions and prohibits the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset. However, it is permissible for final datasets in machine-readable format to be submitted to and accessed from PubMed Central (and similar sites) provided that care is taken to ensure that the individuals cannot be re-identified using other publicly available information.

Shared Documents
STUDY PROTOCOL
Time Frame
Controlled access requests will be provided to the greatest extent possible under specific DUAs or other written agreements and open access will be provided to the final datasets underlying peer-reviewed publications in accordance with the research disposition policy which states that research records will be destroyed 6 years after cutoff (at the end of the fiscal year) after completion of the research project, but may be retained longer if required by other federal regulations or sponsor archive requirements.
Access Criteria
Controlled access requests will be provided to the greatest extent possible under specific DUAs or other written agreements and open access will be provided to the final datasets underlying peer-reviewed publications in accordance with the research disposition policy which states that research records will be destroyed 6 years after cutoff (at the end of the fiscal year) after completion of the research project, but may be retained longer if required by other federal regulations or sponsor archive requirements.

Locations